Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fenfluramine binds 5-hydroxytryptophan.

R S Root-Bernstein, F C Westall

    Brain Research Bulletin
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Fenfluramine, an autism treatment, may work by binding to 5-hydroxytryptophan, a precursor to serotonin. This discovery offers insights into drug activity and receptor binding mechanisms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Therapeutic AIDS vaccines.

    Current pharmaceutical design·2006
    Same author

    Antioxidant-independent ascorbate enhancement of catecholamine-induced contractions of vascular smooth muscle.

    American journal of physiology. Heart and circulatory physiology·2004
    Same author

    Insulin binds to glucagon forming a complex that is hyper-antigenic and inducing complementary antibodies having an idiotype-antiidiotype relationship.

    Autoimmunity·2001
    Same author

    Natural electrophoresis of norepinephrine and ascorbic acid.

    Biophysical journal·2000
    Same author

    Toward a philosophy of cancer research.

    Anticancer research·2000
    Same author

    A simple stochastic model of development and carcinogenesis.

    Anticancer research·2000

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Biochemistry

    Background:

    • Fenfluramine is an anorexigenic drug used for autism treatment.
    • Its precise mechanism of action remains unknown.
    • It is known to affect serotonin (5-hydroxytryptamine) and 5-hydroxyindoleacetic acid levels.

    Purpose of the Study:

    • To investigate the molecular mechanism of fenfluramine's action.
    • To identify potential binding targets of fenfluramine.
    • To explore the implications for drug design and receptor binding.

    Main Methods:

    • Chromatography was employed to analyze fenfluramine interactions.
    • Nuclear magnetic resonance (NMR) spectroscopy was used to elucidate binding modes.
    • The study focused on fenfluramine's interaction with 5-hydroxytryptophan.

    Related Experiment Videos

    Main Results:

    • Evidence suggests fenfluramine selectively binds to 5-hydroxytryptophan.
    • 5-Hydroxytryptophan is a precursor to serotonin and 5-hydroxyindoleacetic acid.
    • This binding interaction was confirmed through chromatography and NMR spectroscopy.

    Conclusions:

    • Fenfluramine's mode of action may involve selective binding to 5-hydroxytryptophan.
    • Understanding this binding can advance the study of drug activity and receptor interactions.
    • This finding could aid in designing specific antagonists for aromatic compounds.